Analytic Investors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BIT
BFA
Analytic Investors's LLY Position: Q3 2016 in Review
Analytic Investors sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 597,711 shares — an estimated $47.1M sold.
Analytic Investors first reported a position in LLY in Q2 2013 and held it in 13 quarters. The position peaked at $149M in Q1 2015. 1,176 funds tracked by Wall St. Rank hold LLY as of Q3 2016.
- Analytic Investors reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
- Analytic Investors sold 597,711 Eli Lilly shares in Q3 2016, an estimated $47.1M.
- Analytic Investors first reported a position in Eli Lilly in Q2 2013 and held it in 13 quarters.
- Analytic Investors's Eli Lilly position peaked at $149M in Q1 2015.
- 1,176 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.
Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.